Vizgen

United States
Primghar, Iowa, United States, 02138

Company profile

Vizgen company profile

Vizgen is a life sciences technology company that develops advanced spatial biology and multi-omics platforms to help scientists map and understand gene and protein expression within intact tissues at single-cell resolution. Its core technologies include MERFISH 2.0, a high-plex spatial transcriptomics method that enables detailed visualization of thousands of RNA molecules while preserving spatial context, and the MERSCOPE imaging platforms that support comprehensive spatial genomics experiments with high sensitivity and reproducibility. Complementing transcriptomic data, Vizgen’s InSituPlex® multiplex immunofluorescence proteomics assays and STARVUE™ AI-driven image analysis tools enable quantitative protein detection and the integration of RNA-protein insights, empowering researchers to explore complex biological systems, such as tumor microenvironments, immune landscapes, and tissue architecture. Vizgen’s platforms are designed to accelerate breakthroughs in understanding disease mechanisms and advancing drug discovery by enabling unprecedented views into cellular organization and molecular interactions within tissues.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2019-03-07

Headquarters

Postal code
02138
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
6
Total equity funding
$184.2M
Last funding
Series E / $48M / 2026-01-08
Last equity funding
Series E / $48M
Investors
9
Lead investors
5
Founders
3
Articles
90

Founders and investors

Founders

David R. WaltGeorge EmanuelJiang He

Lead investors

ARCH Venture PartnersBlue Water Life Science AdvisorsM VenturesNorthpond VenturesNovalis LifeSciences

Investors

ARCH Venture PartnersNorthpond VenturesNovalis LifeSciencesPura Vida InvestmentsSofina